IGeneX Overview
- Year Founded
-
1991
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
4
IGeneX General Information
Description
Provider of laboratory and research services intended for private physicians, hospitals and other clinical laboratories. The company's services include laboratory research and testing in a comprehensive way to test relevant strains of tick-borne pathogens, including those pathogens and different treatment paths, thereby enabling patients to make a timely diagnosis for starting the right treatment.
Contact Information
Website
www.igenex.comCorporate Office
- 556 Gibraltar Drive
- Milpitas, CA 95035
- United States
Corporate Office
- 556 Gibraltar Drive
- Milpitas, CA 95035
- United States
IGeneX Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IGeneX Comparisons
Industry
Financing
Details
IGeneX Competitors (5)
One of IGeneX’s 5 competitors is ARUP Laboratories, a Corporation company based in Salt Lake City, UT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ARUP Laboratories | Corporation | Salt Lake City, UT | ||||
| Genova Diagnostics | Private Equity-Backed | Asheville, NC | ||||
| EUROFINS Genoma Group | Venture Capital-Backed | Rome, Italy | ||||
| NeoGenomics | Corporation | Fort Myers, FL | ||||
| Igenomix USA | Formerly PE-Backed | Paterna, Spain |
IGeneX Patents
IGeneX Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2013122611-A2 | New method for decontamination and processing of clinical specimens from a patient | Inactive | 13-Feb-2012 | ||
| WO-2013122611-A3 | New method for decontamination and processing of clinical specimens from a patient | Inactive | 13-Feb-2012 | ||
| AU-2003265467-A1 | Assay for detection of antigen in bodily fluid | Inactive | 16-Aug-2002 | ||
| AU-2003265467-A8 | Assay for detection of antigen in bodily fluid | Inactive | 16-Aug-2002 | ||
| WO-2004016804-A2 | Assay for detection of antigen in bodily fluid | Inactive | 16-Aug-2002 | G01N33/54366 |
IGeneX Signals
IGeneX Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
IGeneX FAQs
-
When was IGeneX founded?
IGeneX was founded in 1991.
-
Where is IGeneX headquartered?
IGeneX is headquartered in Milpitas, CA.
-
What is the size of IGeneX?
IGeneX has 50 total employees.
-
What industry is IGeneX in?
IGeneX’s primary industry is Laboratory Services (Healthcare).
-
Is IGeneX a private or public company?
IGeneX is a Private company.
-
What is IGeneX’s current revenue?
The current revenue for IGeneX is .
-
Who are IGeneX’s investors?
4C Capital and Promise Holdings have invested in IGeneX.
-
Who are IGeneX’s competitors?
ARUP Laboratories, Genova Diagnostics, EUROFINS Genoma Group, NeoGenomics, and Igenomix USA are competitors of IGeneX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process